Möchten Sie immer auf dem neuesten Stand bleiben?

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial)  Pivotal Phase 2 first interim analysis expected in Q4 2026BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01...

MILWAUKEE, May 11, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of April 30, 2026 totaled...

Annual subscription revenue rose to 57.4% of total revenue in Q1Corporate, now over 60% of total revenue, continues to grow, up nearly 6% year over yearCompany maintains full-year 2026 revenue and...

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Kaltura, Inc. (Nasdaq: KLTR, “Kaltura” or the “Company”), the Agentic Digital Experience company, today announced financial results for the first quarter...

The Company achieved Q1 2026 record-breaking results across key metrics, including Paying Circles, Global Net Additions, and Subscription Revenue.

MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...

Delivered Revenue Within Guidance Range and Adjusted EBITDA Well Above the High-End of Guidance Range First Quarter Revenue Decline of 1.5% Year-Over-Year; Revenue Growth on a Constant Currency Basis...

BERKELEY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced financial...

Research partnerships with Arizona State University, Rensselaer Polytechnic Institute and Stanford University accelerate the U.S. lab-to-fab innovation pipeline by combining academic insights with...

– LOQTORZI® net revenue of $11.8 million in Q1 2026 – – Patient accrual complete for 1L HCC Phase 2 randomized clinical trial for anti-IL27 casdozokitug, timing for data readouts tracking to...